US Patent

US10925896 — Pharmaceutical compositions

Formulation · Assigned to Vifor Fresenius Medical Care Renal Pharma Ltd · Expires 2028-11-13 · 2y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical compositions for oral administration that contain high-loading iron oxy-hydroxide.

USPTO Abstract

Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.

Drugs covered by this patent

ferric-oxyhydroxide (FERRIC OXYHYDROXIDE)

Patent Metadata

Patent number: US10925896
Jurisdiction: US
Classification: Formulation
Expires: 2028-11-13
Drug substance claim: No
Drug product claim: Yes
Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.